Following peer review, applications are passed to the NIH’s funding institutes and centers, such as the National Institute of Allergy and Infectious Diseases (NIAID) or the National Cancer Institute ...

Researchers from the University of Wisconsin-Madison and the University of Florida have discovered a treatment for placentas ...

A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...

On January 6, 2025, the US Food and Drug Administration (FDA) and the US Department of Health and Human Services (HHS) Office for Human ...

A modified herpes virus that targets spinal cord nerve cells to treat neurogenic bladder in people with spinal cord injury is underway in a first-in-human clinical trial by UTHealth Houston at TIRR ...

The potential applications of artificial intelligence (AI) in biopharmaceuticals appear wide-ranging and transformative.

YPrime, the leading pioneer in clinical trial technology, today announced it has earned a top-tier EcoVadis rating and medal, ...

Phase 3 AURORA trial of Descartes-08 in myasthenia gravis on track to commence in 1H25; Deep and durable responses maintained over 12 months in ...

Researchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine.

VERITAC-2 achieved its primary endpoint in the estrogen receptor 1-mutant population, demonstrating statistically significant and clinically ...

The drug, which works by blocking HIV from entering and multiplying in human cells, remained in the body for at least 56 ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.